{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:10:40Z","timestamp":1648894240186},"reference-count":30,"publisher":"Japanese Pharmacological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacologica Japonica","Folia Pharmacol. Jpn."],"published-print":{"date-parts":[[2001]]},"DOI":"10.1254\/fpj.118.303","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T06:04:58Z","timestamp":1081836298000},"page":"303-308","source":"Crossref","is-referenced-by-count":1,"title":["Monoaminergic anorectic agents"],"prefix":"10.1254","volume":"118","author":[{"given":"Koji","family":"FUKAGAWA","sequence":"first","affiliation":[{"name":"1st Department of Internal Medicine, Oita Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiie","family":"SAKATA","sequence":"additional","affiliation":[{"name":"1st Department of Internal Medicine, Oita Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Leibowitz SF: Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci 15, 491-497 (1992)","DOI":"10.1016\/0166-2236(92)90101-D"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Boden PR, Woodruff GN and Pinnock RD: Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurons in the dorsal raphe of the rat brain. Br J Pharmacol 102, 635-638 (1991)","DOI":"10.1111\/j.1476-5381.1991.tb12225.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Grignaschi G, Mantelli B, Fracasso C, Anelli M, Caccia S and Samanin R: Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats. Br J Pharmacol 109, 491-494 (1993)","DOI":"10.1111\/j.1476-5381.1993.tb13596.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, Moore GB, Piercy V, Carter SA, Lehner I, Smith SA, et al: Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 406, 415-418 (2000)","DOI":"10.1038\/35019082"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Nonogaki K, Strack A, Dallaman M and Tecott LH: Leptin-independent hyperphagia and type2 diabetes in mice with a mutated serotonin 5-HT2c rceptor gene. Nat Med 4, 1152-1156 (1998)","DOI":"10.1038\/2647"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Blundell JE, Lawton CL and Halford JC: Serotonin, eating behavior and fat intake. Obes Res 3 Suppl 4, 471S (1995)","DOI":"10.1002\/j.1550-8528.1995.tb00214.x"},{"key":"7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2165\/00003495-199652050-00007","volume":"52","year":"1996","unstructured":"8) Davis R and Faulds D: Dexfenfluramine an updated review of its therapeutic use in the management of obesity. Drugs 52, 696-724 (1996)","journal-title":"Drugs","ISSN":"http:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"8","doi-asserted-by":"publisher","unstructured":"9) McTavish D and Heel RC: Dexfenfluramine. A review of its pharmacological properties and thrapeutic potential in obesity. Drugs 43 (5), 713-733 (1992)","DOI":"10.2165\/00003495-199243050-00007"},{"key":"9","doi-asserted-by":"publisher","unstructured":"10) Fattaccini CM, Gozlan H and Hamon M: Differential effects of d-fenfluramine and p-chloroamphetamine on H75\/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Neuropharmacology 30, 15-23 (1991)","DOI":"10.1016\/0028-3908(91)90037-C"},{"key":"10","doi-asserted-by":"publisher","unstructured":"11) Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefevre P and Turner P: International trial of long-term dexfenfluramine in obesity. Lancet 2, 1142-1145 (1989)","DOI":"10.1016\/S0140-6736(89)91499-2"},{"key":"11","doi-asserted-by":"publisher","unstructured":"12) Silverstone T: Appetite suppressants. Drugs 43 (6), 820-836 (1992)","DOI":"10.2165\/00003495-199243060-00003"},{"key":"12","unstructured":"13) Fuller RW, Wong DT and Robertson DW: Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev 11, 173-34 (1989)"},{"key":"13","doi-asserted-by":"crossref","unstructured":"15) Leibowitz SF, Roossin P and Rosenn M: Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the rat. Pharmacol Biochem Behav 21, 801-808 (1984)","DOI":"10.1016\/S0091-3057(84)80022-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"16) Oltmans GA: Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob\/ob). Brain Res 273, 369-373 (1983)","DOI":"10.1016\/0006-8993(83)90865-X"},{"key":"15","doi-asserted-by":"publisher","unstructured":"17) Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14, 141-148 (1977)","DOI":"10.1007\/BF00429772"},{"key":"16","doi-asserted-by":"crossref","unstructured":"18) Leibowitz SF: Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci 15, 491-497 (1992)","DOI":"10.1016\/0166-2236(92)90101-D"},{"key":"17","doi-asserted-by":"crossref","unstructured":"19) Salamone JD, Mahan K and Rogers S: Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacol Biochem Behav 44, 605-610 (1993)","DOI":"10.1016\/0091-3057(93)90174-R"},{"key":"18","doi-asserted-by":"crossref","unstructured":"20) Szczypka MS, Rainey MA, Kim DS, Alaynick WA, Marck BT, Matsumoto AM and Palmiter RD: Feeding behavior in dopamine-deficient mice. Proc Natl Acad Sci USA 96, 12138-12143 (1999)","DOI":"10.1073\/pnas.96.21.12138"},{"key":"19","unstructured":"21) Sakata T, Fujimoto K, Terada K, Arase K and Fukushima M: Changes in meal pattern and endogenous feeding related substances following mazindol administration. Arch Int Pharmacodyn Ther 270, 11-28 (1984)"},{"key":"20","unstructured":"23) Shiraishi T: Effects of the non-amphetaminergic anorexiant, mazindol, on neuronal activity and hypothalamic control of gastric acid secretion in rats. Int J Obes 9, 285-297 (1985)"},{"key":"21","doi-asserted-by":"crossref","unstructured":"24) Gotestam KG and Gunne LM: Subjective effects of two anorexigenic agents fenfluramine and AN 448 in amphetamine-dependent subjects. Br J Addict Alcohol Other Drugs 67, 39-44 (1972)","DOI":"10.1111\/j.1360-0443.1972.tb01166.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"27) Ryan DH, Kaiser P and Bray GA: Sibutramine: a novel new agent for obesity treatment. Obes Res 3 Suppl 4, 553S-559S (1995)","DOI":"10.1002\/j.1550-8528.1995.tb00227.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"28) Astrup A, Hansen DL, Lundsgaard C and Toubro S: Sibutramine and energy balance. Int J Obes Relat Metab Disord 22, Suppl 1, S30-S35 (1998)","DOI":"10.1038\/sj.ijo.0800614"},{"key":"24","unstructured":"29) Van Gaal LF, Wauters MA, Peiffer FW and De Leeuw IH: Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal\/viscreal fat reduction? Int J Obes Relat Metab Disord 22, Suppl 1, S38-S40 (1998)"},{"key":"25","doi-asserted-by":"crossref","unstructured":"30) Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, et al: Sibutramine produces dose-related weight loss. Obes Res 7, 189-198 (1999)","DOI":"10.1002\/j.1550-8528.1999.tb00701.x"},{"key":"26","doi-asserted-by":"publisher","unstructured":"31) Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M and Sakata T: Hypothalamic neruronal histamine as a target of leptin in feeding behavior. Diabetes 48, 2286-2291 (1999)","DOI":"10.2337\/diabetes.48.12.2286"},{"key":"27","doi-asserted-by":"crossref","unstructured":"32) Sakata T, Ookuma K, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T and Wada H: Blockade of the histamine H<SUB>1<\/SUB>-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res 16, 403-407 (1988)","DOI":"10.1016\/0006-8993(88)91423-0"},{"key":"28","doi-asserted-by":"publisher","unstructured":"33) Kjaer A, Larsen PJ, Knigge U and Warberg J: Histaminergic activation of the hypothalamicpituitary-adrenal axis. Endocrinology 135, 1171-1177 (1994)","DOI":"10.1210\/en.135.3.1171"},{"key":"29","doi-asserted-by":"crossref","unstructured":"34) Kang M, Yoshimatsu H, Kurokawa M, Ogawa R and Sakata T: Prostaglandin E<SUB>2<\/SUB> mediates activation of hypothalamic histamine by interleukin-1 beta in rats. Proc Soc Exp Biol Med 220 ,88-93 (1999)","DOI":"10.3181\/00379727-220-44349"},{"key":"30","doi-asserted-by":"crossref","unstructured":"35) Fujise T, Yoshimatsu H, Kurokawa M, Oohara A, Kang M, Nakata M and Sakata T: Satiation and masticatory function modulated by brain histamine in rats. Proc Soc Biol Med 217, 228-234 (1998)","DOI":"10.3181\/00379727-217-44227"}],"container-title":["Folia Pharmacologica Japonica"],"original-title":["\u4e2d\u67a2\u6027\u30e2\u30ce\u30a2\u30df\u30f3\u5236\u5fa1\u7cfb"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/118\/5\/118_5_303\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T23:39:46Z","timestamp":1585697986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/118\/5\/118_5_303\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.118.303","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001]]}}}